India’s Drug Regulator Approves Two Vaccines for Coronavirus

0
756
Covid Vaccines
Covid Vaccines

Two vaccines for coronavirus, Oxford Institute’s Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech’s Covaxin, received emergency approval from the country’s drug regulator . “We’ll never approve anything if there is slightest of safety concern.

The vaccines are 110 per cent safe,” Drug Controller General of India VG Somani said, adding Covishield was found to be 70.42 percent effective and Bharat Biotech’s Covaxin was “safe and provides a robust immune response”. Hailing the scientific community and frontline Corona warriors, Prime Minister Narendra Modi tweeted, “It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India”. There is no word yet on when the vaccination process will begin.

Both vaccines have to be administered in two doses and stored at temperatures between 2 and 8 degrees Celsius. The government will give priority to 1 crore healthcare workers and 2 crore frontline workers when the vaccinations begin, Union Health Minister Dr. Harshvardhan said as a countrywide dry run for the vaccination process was conducted.

LEAVE A REPLY

Please enter your comment!
Please enter your name here